GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Shiller PE Ratio

TaiMed Biologics (ROCO:4147) Shiller PE Ratio : (As of May. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


TaiMed Biologics Shiller PE Ratio Historical Data

The historical data trend for TaiMed Biologics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Shiller PE Ratio Chart

TaiMed Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TaiMed Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TaiMed Biologics's Shiller PE Ratio

For the Biotechnology subindustry, TaiMed Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TaiMed Biologics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiMed Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TaiMed Biologics's Shiller PE Ratio falls into.



TaiMed Biologics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TaiMed Biologics's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, TaiMed Biologics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.06/131.7762*131.7762
=-0.060

Current CPI (Mar. 2024) = 131.7762.

TaiMed Biologics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.237 100.560 -0.311
201409 -0.355 100.428 -0.466
201412 -0.367 99.070 -0.488
201503 -0.286 99.621 -0.378
201506 -0.503 100.684 -0.658
201509 -0.848 100.392 -1.113
201512 -0.493 99.792 -0.651
201603 -0.227 100.470 -0.298
201606 -0.276 101.688 -0.358
201609 -0.197 101.861 -0.255
201612 -0.434 101.863 -0.561
201703 -0.315 102.862 -0.404
201706 -0.680 103.349 -0.867
201709 -0.414 104.136 -0.524
201712 -0.660 104.011 -0.836
201803 0.493 105.290 0.617
201806 0.237 106.317 0.294
201809 -1.400 106.507 -1.732
201812 -0.601 105.998 -0.747
201903 -0.355 107.251 -0.436
201906 -0.325 108.070 -0.396
201909 -1.262 108.329 -1.535
201912 -0.325 108.420 -0.395
202003 -0.296 108.902 -0.358
202006 0.118 108.767 0.143
202009 -0.177 109.815 -0.212
202012 -0.365 109.897 -0.438
202103 0.020 111.754 0.024
202106 -0.384 114.631 -0.441
202109 -0.306 115.734 -0.348
202112 -1.173 117.630 -1.314
202203 -0.463 121.301 -0.503
202206 -0.296 125.017 -0.312
202209 -0.138 125.227 -0.145
202212 -0.148 125.222 -0.156
202303 -0.320 127.348 -0.331
202306 -0.187 128.729 -0.191
202309 -0.020 129.860 -0.020
202312 -0.237 129.419 -0.241
202403 -0.060 131.776 -0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


TaiMed Biologics  (ROCO:4147) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


TaiMed Biologics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiMed Biologics (ROCO:4147) Business Description

Traded in Other Exchanges
N/A
Address
No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492
TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines